Sign In
En fran├žais Register Now Forgot Password

Back to Program > Cannabinoids In Clinical Practice - An Overview

Contributors
Chair: Dr. Mark Ware
Montreal, QC
 

Committee Members:

Dr. Peter Blecher
Oshawa, ON  
Dr. Ken Chisholm
Halifax, NS  
Dr. Gordon Ko
Toronto, ON  
Dr. Pam Squire
Vancouver, BC  
Dr. Aline Boulanger
Montreal, QC  
Dr. John Clark
Halifax, NS  
Dr. Colleen O.Connell
Fredericton, NB  
Dr. Ken Stakiw
Saskatoon, SK  
Dr. Stewart Cameron
Halifax, NS  
Dr. Paul Daeninck
Winnipeg, MB  
Dr. David Shulman
Toronto, ON  
Dr. Dwight Stewart
Kitchener, ON  
 

The following section includes background on the needs and objectives for the Accredited Cannabinoid Education (ACE) program as well as a general overview of cannabinoids, including history, mechanism of action, clinical potential and avalailable cannabinoids in Canada.

Learning Objectives
  • Identify evidence supporting the use of cannabinoids
  • Outline potential adverse effects
  • Be aware of potential patient concerns regarding cannabinoids
  • Devise an individualized dose titration schedule